Top Markets
Coin of the day
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Rangering i aksjer #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Aksjekurs
$14.66
Sist synkronisert: 2026-08-28
Markedsverdi
$839.37M
Endring (1 dag)
-2.67%
Endring (1 år)
557.32%
Land
US
Handel Climb Bio, Inc. (CLYM)

Kategori

Aksjeprishistorikk for Climb Bio, Inc. (CLYM)
Høyeste sluttskurs: $15.73 den 2026-08-01

Laveste sluttskurs: $7.23 den 2024-09-01
Aksjeprishistorikk for Climb Bio, Inc. fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 113.43%
2025 31.56%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH